Feb 15 2011
As the prevalence of diabetes continues to increase at alarming rates affecting more than 24 million Americans, the creation of the Florida Hospital – Sanford Burnham Translational Research Institute for Metabolism and Diabetes (TRI) will take the prevention, diagnosis, and treatment of diabetes and obesity to the next level.
Designed by Flad Architects, the state-of-the-art, 54,000-square-foot translational research facility will focus on the study of diabetes, obesity, and the metabolic origins of cardiovascular disease, bridging the gap between the research lab and the patient's bedside – allowing for scientific discoveries and treatments to be developed more quickly and on a more personalized level.
"We are witnessing an epidemic of obesity and diabetes in the United States. Current statistics show that two-thirds of all Americans are overweight and obese and 1 in 12 has some form of diabetes," said Dr. Steven Smith, scientific director of the TRI. "These staggering statistics call for decisive action and that includes innovative research. The main goal of the TRI is to generate new knowledge to improve lives through research."
The TRI will bring scientists, clinicians, and the procedures necessary to facilitate translational research together under one roof. The three-story building will contain clinic space, testing rooms, medical imaging, a biorepository, chemistry laboratories, exam rooms, overnight observation rooms, and advanced technologies to develop personalized treatments.
This new research facility, expected to be completed by the end of 2011, will be a landmark building for Florida Hospital, and the signature building in their new Health Village in Orlando.
Source: http://www.flad.com/